Skipping Exon-v6 from CD44v6-Containing Isoforms Influences Chemotherapy Response and Self-Renewal Capacity of Gastric Cancer Cells

De novo expressed CD44 isoforms containing exon-v6 are frequently associated with gastric cancer (GC) aggressiveness, and may predict chemotherapy response in vitro. Whether exon-v6 itself is responsible for conferring these properties to CD44v6-containing isoforms remains to be elucidated. CRISPR/C...

Descripción completa

Detalles Bibliográficos
Autores principales: Lobo, Silvana, Pereira, Carla, Oliveira, Carla, Almeida, Gabriela M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564355/
https://www.ncbi.nlm.nih.gov/pubmed/32842638
http://dx.doi.org/10.3390/cancers12092378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564355/
https://www.ncbi.nlm.nih.gov/pubmed/32842638
http://dx.doi.org/10.3390/cancers12092378

Ejemplares similares